{
  "denotations": [
    {
      "id": "T1",
      "obj": "Disease",
      "span": {
        "begin": 56,
        "end": 64
      }
    },
    {
      "id": "T6",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 96,
        "end": 111
      }
    },
    {
      "id": "T7",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 114,
        "end": 120
      }
    },
    {
      "id": "T8",
      "obj": "Chemical",
      "span": {
        "begin": 135,
        "end": 144
      }
    },
    {
      "id": "T9",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 147,
        "end": 154
      }
    },
    {
      "id": "T10",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 157,
        "end": 162
      }
    },
    {
      "id": "T11",
      "obj": "Chemical",
      "span": {
        "begin": 182,
        "end": 185
      }
    }
  ],
  "sourcedb": "PubMed",
  "sourceid": "18589587_5",
  "text": "A population with slow acetylation has a higher risk of toxicity , as that potent inhibition of cytochrome P450 ( CYP450 ) isoforms by isoniazid ( CYP2C19 y CYP3A ) are dependent of INH plasmatic concentration ."
}
